ADD & ADHD Help Center An independent plain-language reference

Phenylalanine and DLPA

Two mirrored crystalline forms representing mirror-image molecules

DLPA is an abbreviation for DL-phenylalanine, a supplement form combining two mirror-image versions of the amino acid phenylalanine. This page explains what phenylalanine is, what the D and L designations mean, and what is and is not established about the combination. It contains no doses and recommends nothing.

For general background on amino acids, MedlinePlus maintains a reference page from the U.S. National Library of Medicine.

What Phenylalanine Is

Phenylalanine is an essential amino acid — one of the amino acids the human body cannot synthesise, which must therefore come from diet. Amino acids are the building blocks of proteins, and they also serve as precursors for other molecules the body constructs.

It is abundant in ordinary food. Protein-containing foods generally supply it: meat, fish, eggs, dairy products, soy, legumes, nuts and seeds. People eating adequate protein obtain it without difficulty.

What the D and L Forms Mean

Many molecules exist in two mirror-image forms, described as D- and L-. The distinction matters biologically because enzymes are shape-specific and generally recognise only one.

L-phenylalanine is the form that occurs naturally in food proteins and that the body incorporates into its own proteins. It is also a precursor in the pathway leading to tyrosine and onward to the catecholamine neurotransmitters, including dopamine and norepinephrine — which is the reason it appears in discussions of mood and attention.

D-phenylalanine is a synthetic mirror form not used in protein synthesis. It has been studied for other proposed effects.

DL-phenylalanine (DLPA) is a mixture of the two, marketed as a supplement.

The Precursor Reasoning, and Its Limits

The argument commonly made for phenylalanine supplementation is that it is a precursor to dopamine and norepinephrine, that these neurotransmitters are involved in attention and mood, and that supplying more precursor should therefore improve those functions.

The first two steps are accurate biochemistry. The conclusion does not follow from them. Neurotransmitter synthesis is regulated at multiple points, and precursor supply is not usually the limiting factor — so increasing the input does not reliably increase the output. This is the same reasoning error discussed on the choline page, and it is worth recognising as a pattern, because it underlies a great many supplement claims.

Establishing whether supplementation produces a clinical effect requires trials of the specific question, not an argument from mechanism. For ADHD specifically, the National Center for Complementary and Integrative Health maintains the current summary of complementary approaches and their evidence status, and is the appropriate reference.

An Important Safety Exception

One point on this page is genuinely critical rather than merely informative.

People with phenylketonuria (PKU) cannot metabolise phenylalanine normally and must restrict their intake of it. PKU is an inherited metabolic disorder screened for at birth in many countries; without dietary management, accumulated phenylalanine causes serious harm. For someone with PKU, a phenylalanine supplement is not a neutral product.

This is also why products containing the sweetener aspartame carry phenylalanine warnings — aspartame releases phenylalanine when metabolised. If PKU is present or suspected in a family, this is a matter for a clinician and a dietitian.

Other Safety Considerations

Beyond PKU, general cautions apply. Amino acid supplements can interact with prescribed medicines — those affecting neurotransmitter systems particularly — so a prescriber should be told about anything being taken. Dietary supplements in the United States are regulated differently from medicines and do not require pre-market approval for effectiveness; MedlinePlus explains what that means in practice. And, as with choline, being essential does not mean being harmless in any quantity.

Why This Page Exists

Phenylalanine appears on this site as a reference entry because it is a substance readers encounter in ADHD discussion and are entitled to a neutral description of. Nothing here suggests taking it, and no dose appears anywhere on this page.

For the broader dietary question see diet and nutrition, and for the general position on complementary approaches see the range of approaches.

Informational only. This page explains general concepts and summarises what public health authorities publish. It is not medical advice, not a diagnosis, and not a treatment recommendation. Decisions about assessment, medication and support belong with a qualified clinician who knows the person involved.